Orencia

(abatacept)
NO BOXED WARNING

Dosage & Administration

Intravenous Use for Adult RA (2.1) and Adult PsA (2.3)

Body Weight of PatientDoseNumber of Vials

Less than 60 kg

500 mg

2

60 to 100 kg

750 mg

3

More than 100 kg

1,000 mg

4

Subcutaneous Use for Adult RA (2.1)


Intravenous Use for pJIA in Pediatric Patients ≥6 Years Old (2.2)


Subcutaneous Use for pJIA and PsA in Pediatric Patients ≥2 Years Old (2.2)


Body Weight of Pediatric PatientDose (once weekly)

10 kg to less than 25 kg

50 mg

25 kg to less than 50 kg

87.5 mg

50 kg or more

125 mg

Subcutaneous Use for Adult PsA


Intravenous Use for Prophylaxis of aGVHD (2.4)


Preparation and Administration Instructions


Get Your Patient on Orencia

See your patient's specific prior authorization requirements including coverage restrictions and step therapies
Or select your Insurance from the list below:

Orencia Prescribing Information

Orencia Prior Authorization Resources

Most recent state uniform prior authorization forms

Orencia PubMed™ News